Intelligent Diagnosis and Treatment System for Pelvic Floor Dysfunction in Elderly Women
Launched by BEIJING HOSPITAL · Apr 16, 2024
Trial Information
Current as of November 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new smart system designed to help diagnose and treat pelvic floor problems in older women. Specifically, it aims to understand how to identify differences in pelvic floor muscle function early on and create personalized treatment plans based on these differences. The study will compare the results and costs of treatments for women using this intelligent system with those who are not. All examinations and treatments involved are non-invasive, meaning they won't require any surgery or significant discomfort.
To participate, women must be over 60 years old and meet certain health criteria. Unfortunately, those with severe pelvic organ issues, a history of pelvic surgery, or certain medical conditions won't be eligible. Women who join the study can expect to undergo assessments of their pelvic floor health and receive tailored training programs to help improve their condition. This trial is still looking for participants, so it's a great opportunity for eligible women to contribute to important research that could lead to better care for pelvic floor dysfunction.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Women over 60 years old.
- Exclusion Criteria:
- • Severe pelvic organ prolapse (POP-Q stage\>III)
- • History of pelvic floor surgery
- • Malignant tumor in pelvic
- • Allergic to nickel
- • Acute inflammation of pelvic or genital tract
- • Subjects who has cognitive impairment and cannot sign an informed consent
About Beijing Hospital
Beijing Hospital, a prestigious medical institution in China, is dedicated to advancing healthcare through innovative clinical research and trials. With a focus on providing high-quality patient care and fostering medical excellence, the hospital collaborates with leading researchers and healthcare professionals to explore new treatment modalities and improve patient outcomes. Its commitment to rigorous scientific methodology and ethical standards ensures that all clinical trials conducted under its auspices contribute valuable insights to the medical community and enhance the overall health landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, Beijing, China
Patients applied
Trial Officials
Mi Li, Ph.D.
Study Chair
Beijing Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported